Japan could offer unapproved Ebola drug

Send a link to a friend  Share

[August 25, 2014] TOKYO (Reuters) - Japan would like to offer a drug to help treat the deadly Ebola virus before the World Health Organization officially rules on its use, the country's top government spokesman said on Monday.  

Chief Cabinet Secretary Yoshihide Suga told a news conference that Japan has received inquiries from some countries on the influenza drug favipiravir, or T-705 as it is known in the developmental code.

"I am informed that medical professionals could make a request for T-705 in an emergency even before a decision (on approval) by the WHO. In that case, we would like to respond under certain criteria," he said.

Japan's Fujifilm Holdings Corp and U.S. partner MediVector are in talks with the U.S. Food and Drug Administration to submit an application to expand the use of favipiravir as a treatment for Ebola.

Following Suga's comments, Fujifilm shares rose 4.0 percent, edging near a four-year peak hit earlier this month. They were the eighth most actively traded shares on the Tokyo Stock Exchange's main board.

The Ebola epidemic in West Africa has killed more than 1,000 people and prompted the WHO to declare an international health emergency.

[to top of second column]

(Reporting by Kaori Kaneko and Tomo Uetake; Editing by Chris Gallagher and Jeremy Laurence)

[ 2014 Thomson Reuters. All rights reserved.]

Copyright 2014 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

< Recent articles

Back to top